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1. Introduction {#feb2s0014579305011932-sec-1}
===============

Severe acute respiratory syndrome‐associated coronavirus (SARS‐CoV) causes bronchial epithelial denudation, loss of cilia, and multinucleated in lung tissues \[[1](#feb2s0014579305011932-bib-bib1){ref-type="ref"}, [2](#feb2s0014579305011932-bib-bib2){ref-type="ref"}\], and induces lymphopenia, leucopenia, and thrombocytopenia in the SARS patients \[[3](#feb2s0014579305011932-bib-bib3){ref-type="ref"}, [4](#feb2s0014579305011932-bib-bib4){ref-type="ref"}\]. The relevance to SARS‐CoV pathogenesis becomes an attractive issue for developing anti‐SARS therapy. SARS‐CoV contains a single positive‐stranded RNA genome that is approximately 30 kb in length and has a 5′ cap structure and 3′ polyA tract \[[5](#feb2s0014579305011932-bib-bib5){ref-type="ref"}, [6](#feb2s0014579305011932-bib-bib6){ref-type="ref"}, [7](#feb2s0014579305011932-bib-bib7){ref-type="ref"}\]. The SARS‐CoV genome encodes for replicase, spike, envelope, membrane, and nucleocapsid. The replicase gene encodes two large overlapping polypeptides (replicase 1a and 1ab, ∼450 and ∼750 kD, respectively), including 3C‐like protease (3CL^pro^), RNA‐dependent RNA polymerase, and RNA helicase for viral replication and transcription [\[8\]](#feb2s0014579305011932-bib-bib8){ref-type="ref"}. The SARS‐CoV 3CL^pro^ mediates the proteolytic processing of replicase polypeptides 1a and 1ab into functional proteins, thereby playing an important role in viral replication. In the case of picornaviruses, poliovirus, enterovirus 71, and rhinovirus, 3C protease have been demonstrated to cleave specific cellular proteins \[[9](#feb2s0014579305011932-bib-bib9){ref-type="ref"}, [10](#feb2s0014579305011932-bib-bib10){ref-type="ref"}\], inhibit the cellular translation \[[11](#feb2s0014579305011932-bib-bib11){ref-type="ref"}, [12](#feb2s0014579305011932-bib-bib12){ref-type="ref"}\], and induce cell apoptosis \[[13](#feb2s0014579305011932-bib-bib13){ref-type="ref"}, [14](#feb2s0014579305011932-bib-bib14){ref-type="ref"}, [15](#feb2s0014579305011932-bib-bib15){ref-type="ref"}\]. Recently, SARS‐CoV 3CL^pro^ cleavage sites have been predicted in cellular proteins such as the cystic fibrosis transmembrane conductance regulator, and transcription factors CREB‐RP and OCT‐1 using computational methods [\[16\]](#feb2s0014579305011932-bib-bib16){ref-type="ref"}, signifying SARS‐CoV 3CL^pro^ protease can be involved in virus‐induced pathology. In this study, we intended to identify potential 3CL^pro^‐interacting cellular protein(s) using the phage‐displayed human lung cDNA library.

2. Materials and methods {#feb2s0014579305011932-sec-2}
========================

2.1. Biopanning of phage display lung cDNA libraries with SARS‐CoV 3CL^pro^ {#feb2s0014579305011932-sec-2.1}
---------------------------------------------------------------------------

The 3CL^pro^‐expressing *E. coli* strain described in our previous report [\[17\]](#feb2s0014579305011932-bib-bib17){ref-type="ref"} was used for generation of recombinant 3CL^pro^ His‐tag fusion protein. For biopanning, the T7Select human lung cDNA library fused at the C terminus of phage capsid protein 10B was purchased from Novagen (Madison, WI). Following the biopanning procedure in our previous report [\[18\]](#feb2s0014579305011932-bib-bib18){ref-type="ref"}, five rounds of biopanning for screening 3CL^pro^‐affinity phage clones were carried out using 3CL^pro^‐coated microplates (5 μg per well). The 3CL^pro^‐affinity phage clones were eluted with the soluble 3CL^pro^. For direct ELISA binding assay, the individual eluted phage clones that were determined using a plaque assay were coated onto microplates (10^10^ p.f.u./well) for 1 h at room temperature. After blocking phage‐coated plates, 100 μl of 20 μg/ml 3CL^pro^ was added to each well for additional 1‐h incubation. Bound 3CL^pro^ was detected using the ELISA with the anti‐His tag monoclonal antibody and anti‐mouse IgG antibodies conjugated to peroxidase (Pharmacia). ELISA product was developed with a chromogen solution containing ABTS (2,2′‐azino‐di‐(3‐ethylbenzthiazoline‐6‐sulfonate)) and hydrogen peroxide and then measured at *A* ~405\ nm~. The lung cDNA genes displayed on 3CL^pro^‐affinity phages were directly amplified using PCR with the T7 Select UP primer 5′‐GGAGCTGTCGTATTCCAGTCA‐3′ and the T7 Select DOWN primer 5′‐CCCCTCAAGACCCGTTTA‐3′. The nucleotide sequences of each PCR product were determined using the sequencing with the ABI PRISM 377 DNA Sequencer (Perkin--Elmer, USA). The deduced amino acid sequences of 3CL^pro^‐interacting lung cDNA clones were aligned using the BLAST search (<http://www.ncbi.nlm.nih.gov/BLAST/>).

2.2. Co‐immunoprecipitation of SARS‐CoV 3CL^pro^ protease by vacuolar‐H^+^ ATPase G1 subunit {#feb2s0014579305011932-sec-2.2}
--------------------------------------------------------------------------------------------

For the cell‐free co‐immunoprecipitation assay, the vacuolar‐H^+^ ATPase gene was cloned into the vector pET32a, and expressed as the fusion protein with thioredoxin (Trx) at the N‐terminus and His‐tag at the C‐terminus. The cDNA of the C‐terminal vacuolar‐H^+^ ATPase subunit G1 displayed on the 3CL^pro^‐affinity phage clone 7 was amplified by PCR with primers: 5′‐ATCCGAATTCGCCAAGGAAGCTGCGG‐3′ and 5′‐CCGCAAGCTTTCCATTTATGCGGTAG‐3′. The PCR product was digested with *EcoR*I and *Hind*III, and then cloned into the *EcoR*I/*Hind*III site of the expression vector pET32a (Novagen). The mixture of 3CL^pro^ and vacuolar‐H^+^ ATPase thioredoxin fusion protein was first incubated with anti‐thioredoxin mAb (Invitrogen) for 4 h at 4 °C, and then reacted with the protein A‐Sepharose beads for the addition of 2‐h incubation. After centrifugation, the pellet was washed four times with NET buffer (150 mM NaCl, 0.1 mM EDTA, 30 mM Tris--HCl, and pH 7.4). The immunoprecipitate was dissolved in a 2× SDS--PAGE sample buffer without 2‐mercaptoethanol and boiled for 10 min. Proteins were resolved on 12% SDS--PAGE gels and electrophoretically transferred to nitrocellulose papers. The resultant blots were blocked with 5% skim milk, and then reacted with the anti‐His tag mAb for 1‐h incubation. The blots were then washed with TBS three times and overlaid with a 1/1000 dilution of rabbit anti‐mouse IgG antibodies conjugated with alkaline phosphatase (KPL). Following another1‐h incubation at room temperature, the blots were developed with NBT/BCIP (Invitrogen).

2.3. ELISA affinity assay {#feb2s0014579305011932-sec-2.3}
-------------------------

The wells of a 96‐well microtiter plate were coated with 100 μl of 5 μg/ml 3CL^pro^ and were incubated at 4 °C overnight. Following each incubation and subsequent layer of the enzyme‐linked immunosorbent assay (ELISA), the wells were washed three times with TBS containing 0.05% Tween 20 (TBST). After blocking with 5% skim milk in TBST, serial dilution of V‐ATPase G1 TRX fusion protein or thioredoxin (TRX) was incubated in 3CL^pro^‐coated wells for 2 h. The bound V‐ATPase G1 TRX fusion protein or TRX protein was detected with the anti‐TRX monoclonal antibody, and then the ELISA product was developed with goat anti‐mouse IgG‐HRP conjugate and ABTS/H~2~O~2~ substrates. The relative affinity, *K* ~d~, was estimated from the concentration necessary for 50% maximal binding based on a computer program employing Fisher\'s statistical model.

2.4. Trans‐cleavage of V‐ATPase G1 by SARS‐CoV 3CL^pro^ protease {#feb2s0014579305011932-sec-2.4}
----------------------------------------------------------------

The SARS‐CoV 3CL^pro^ protease was incubated with the V‐ATPase G1 TRX fusion protein or TRX protein in 100 mM Tri--HCl (pH 9.0) at 37 °C. The proteolytic processing was analyzed using Western blotting with anti‐His tag antibody. Band intensities of the V‐ATPase G1 TRX fusion protein or TRX protein on the nitrocellulose were quantified by densitometric analysis.

2.5. Immunoprecipitates of cell extract by 3CL^pro^ {#feb2s0014579305011932-sec-2.5}
---------------------------------------------------

The 3CL^pro^ gene was cloned into the pcDNA3.1 vector and generated as a His‐tag fusion protein [\[17\]](#feb2s0014579305011932-bib-bib17){ref-type="ref"}. The resulting plasmid pcDNA3.1‐SARS CoV 3CL^pro^ (pSARS‐CoV 3CL^pro^) (4.5 μg) plus indicator vector pEGFP‐N1 (0.5 μg) was transfected into HL‐CZ cells, a human promonocyte cell line [\[19\]](#feb2s0014579305011932-bib-bib19){ref-type="ref"}, using the GenePorter reagent. The cell extract of the 3CL^pro^‐expressing cells and mock cells was incubated with anti‐His tag antibody to 3CL^pro^ for 4 h at 4 °C, and then reacted with the protein A‐Sepharose beads for the addition of 2‐h incubation. The immunoprecipitate was analyzed using Coomassie blue staining, and Western blotting with anti‐His tag antibody to 3CL^pro^ and chicken anti‐V‐ATPase G1 polyclonal antibody (Chemicon).

2.6. Measurement of intracellular pH in transfected cells with SNARF‐1 {#feb2s0014579305011932-sec-2.6}
----------------------------------------------------------------------

Transfected cells were washed three times with PBS and incubated with 20 μM carboxy SNARF‐1 (Molecular Probe) for 30 min at room temperature. Subsequently, the cells were washed with PBS again and then placed into the microplates. A dual‐emission ration at 580 and 640 nm of intracellular dye was detected using a fixed excitation at 514 nm, and then converted to intracellular pH (pH~i~) according to previous reports [\[20\]](#feb2s0014579305011932-bib-bib20){ref-type="ref"}.

3. Results {#feb2s0014579305011932-sec-3}
==========

3.1. Identification of SARS‐CoV 3CL^pro^‐interacting lung protein(s) {#feb2s0014579305011932-sec-3.1}
--------------------------------------------------------------------

For identifying potential 3CL^pro^‐interacting human lung proteins, affinity selection of a phage‐displayed human lung cDNA library with recombinant 3CL^pro^ protein was carried out. After five rounds of biopanning, fifty eluted phage plaques were selected for determining relative affinities to SARS‐CoV 3CL^pro^ using direct binding ELISA assay. Ten of the fifty phage clones, phage‐7, 8, 25, 31, 32, 33, 34, 35, 45, and 46 had higher absorbance values of the ELISA product compared to other phage clones (data not shown here). In addition, these ten selected phage clones showed approximately 3--5‐fold increases in direct ELISA binding compared to the wild type phage T7. Therefore, these ten identified phage clones were suggested to display the high affinity of lung cDNA clones to SARS‐CoV 3CL^pro^.

Lung cDNA clones displayed on these ten 3CL^pro^‐interacting phages were subsequently amplified using PCR. Gel electrophoresis of the PCR products revealed that about 400 base pair products were amplified from eight phage clones, phage‐7, 25, 31, 32, 33, 34, 35, and 46 ([Fig. 1](#feb2s0014579305011932-fig1){ref-type="fig"} A, lanes 2, 4, 5, 6, 7, 8, 9, and 11), and about 300 pair products were found in two phage clones, phage‐8 and 45 ([Fig. 1](#feb2s0014579305011932-fig1){ref-type="fig"}A, lanes 3 and 10). Direct sequencing of the PCR products showed the same nucleotide sequences of lung cDNA clones displayed on phage‐7, 25, 31, 32, 33, 34, 35, and 46 ([Fig. 1](#feb2s0014579305011932-fig1){ref-type="fig"}B). The BLAST alignment search indicated that the deduced amino acid sequence of the 3CL^pro^‐interacting lung cDNA clone was identical to the C‐terminus of vacuolar ATP synthase subunit G 1 (V‐ATPase G1 subunit) (GenBank Accession No. [genbank:O75348](genbank:O75348) and [genbank:NP_004879](genbank:NP_004879)). Interestingly, V‐ATPase G1 contains a motif Thr‐Ile‐Leu‐Gln‐Thr, being similar to the conserved 3CL^pro^ cleavage sites (Val/Thr)‐X‐Leu‐Gln‐(Ser/Ala).

![Gel electrophoresis of PCR products (A) and deduced amino acid sequence (B) from SARS‐CoV 3CL^pro^‐interacting human lung proteins displayed on the identified phage clones. (A) After five rounds of biopanning with SARS‐CoV 3CL^pro^, the human lung cDNA clones displayed on individual eluted phage plaques were amplified using PCR. (B) The amino acid sequence of 3CL^pro^‐interacting human lung protein that was identified from phage Nos. 7, 25, 31, 32, 33, 34, 35, and 46 was deduced from the human lung cDNA nucleotide sequence from 3CL^pro^‐interacting phage No. 7. A dashed‐line box was marked for the possible 3CL^pro^ cleavage site.](FEB2-579-6089-g001){#feb2s0014579305011932-fig1}

3.2. Binding interaction of 3CL^pro^ with V‐ATPase G1 {#feb2s0014579305011932-sec-3.2}
-----------------------------------------------------

To test the specific interaction of 3CL^pro^ with V‐ATPase G1, the identified lung cDNA clone encoding for the C‐terminus of V‐ATPase G1 subunit was cloned into the bacterial expression vector pET32a, being generated as a thioredoxin (TRX) and His‐tag fusion protein in *E. coli*. Co‐immunoprecipitation of the 3CL^pro^ protein with the V‐ATPase G1 TRX fusion protein was performed. After centrifugation, the protein complex was precipitated by the anti‐thioredoxin antibody and the protein A‐Sepharose beads. Western blot analysis of the immunoprecipitate demonstrated that 3CL^pro^ was precipitated by the V‐ATPase G1 TRX fusion protein ([Fig. 2](#feb2s0014579305011932-fig2){ref-type="fig"} A, lane 5) but not the TRX protein ([Fig. 2](#feb2s0014579305011932-fig2){ref-type="fig"}A, lane 2). Furthermore, direct binding of V‐ATPase G1 TRX fusion protein to SARS‐CoV 3CL^pro^ showed a dose‐dependent manner in the ELISA assay ([Fig. 2](#feb2s0014579305011932-fig2){ref-type="fig"}B). The relative binding affinity (*K* ~d~) of the V‐ATPase G1 TRX fusion protein to recombinant 3CL^pro^ protease was approximately 1.9 μM, indicating that the V‐ATPase G1 subunit was sufficient for binding to SARS‐CoV 3CL^pro^.

![The specific interaction of SARS‐CoV 3CL^pro^ with V‐ATPase G1 TRX fusion protein using co‐immunoprecipitation assay (A) and the binding affinity assay (B). (A) An equal amount of V‐ATPase G1 TRX fusion protein and the SARS‐CoV 3CL^pro^ was first incubated with anti‐TRX mAb at 4 °C overnight, followed by incubation with the protein A‐Sepharose beads for the addition of 2‐h incubation. After centrifugation, the pellet was washed with NET buffer, and then dissolved in 2× SDS--PAGE sample buffer without 2‐mercaptoethanol and boiled for 10 min. Following the western blot procedure, the blot was probed with mouse anti‐His tag antibodies, and developed with an alkaline phosphatase‐conjugated secondary antibody and NBT/BCIP substrates. (B) 100 μl of 5 μg/ml 3CL^pro^ was coated onto 96‐well plates; followed by incubation with the indicated concentration of V‐ATPase G1 TRX fusion protein or thioredoxin (TRX). Bound V‐ATPase G1 TRX fusion protein or thioredoxin was detected using anti‐TRX monoclonal antibody. The ELISA product was developed with goat anti‐mouse IgG‐HRP conjugate and ABTS/H~2~O~2~ substrates.](FEB2-579-6089-g002){#feb2s0014579305011932-fig2}

3.3. Cleavage of V‐ATPase G1 by SARS‐CoV 3CL^pro^ {#feb2s0014579305011932-sec-3.3}
-------------------------------------------------

Because the V‐ATPase G1 contains a possible cleavage site for 3CL^pro^, the *trans*‐cleavage reaction of 3CL^pro^ with the V‐ATPase G1 TRX fusion protein was carried out in the alkaline buffer at 37 °C. In Western blot analysis with anti‐His tag antibody, the V‐ATPase G1 TRX fusion protein but not the TRX protein was cleaved by the 3CL^pro^ protease ([Fig. 3](#feb2s0014579305011932-fig3){ref-type="fig"} ). Based on the remaining amount of the V‐ATPase G1 TRX fusion protein, densitometric analysis demonstrated that the percentage of the cleaved V‐ATPase G1 TRX fusion protein reached up to approximately 70% ([Fig. 3](#feb2s0014579305011932-fig3){ref-type="fig"}, lanes 7--9); however, no significant change was found in the amount of the TRX protein ([Fig. 3](#feb2s0014579305011932-fig3){ref-type="fig"}, lanes 3--5).

![*Trans*‐cleavage of V‐ATPase G1 TRX fusion protein by SARS‐CoV 3CL^pro^ protease. The SARS‐CoV 3CL^pro^ protease was incubated with the V‐ATPase G1 TRX fusion protein (lanes 6--9) or TRX protein (lanes 2--5) in 100 mM Tris--HCl, (pH 9.0) at 37 °C, and the proteolytic processing was analyzed using Western blotting with anti‐His tag antibody. Lane 1, protein markers.](FEB2-579-6089-g003){#feb2s0014579305011932-fig3}

3.4. Interaction of SARS‐CoV 3CL^pro^ with cellular V‐ATPase G1 {#feb2s0014579305011932-sec-3.4}
---------------------------------------------------------------

To examine the cell‐based interaction of SARS‐CoV 3CL^pro^ with V‐ATPase G1, the SARS‐CoV 3CL^pro^ gene was cloned into the mammalian expression vector pcDNA3.1, and then transfected into human promonocyte HL‐CZ cells. Western blotting analysis of cell lysates with anti‐His‐tag antibody demonstrated a major 68‐kDa band for the dimer and a minor 34‐kDa band in the 3CL^pro^‐expressing cells (not shown here). For further analyzing the binding of cellular V‐ATPase G1 to 3CL^pro^, the cell lysate of the 3CL^pro^‐expressing cells and mock cells was precipitated by anti‐His tag antibody to 3CL^pro^ ([Fig. 4](#feb2s0014579305011932-fig4){ref-type="fig"} A--C). In the Coomassie‐stained gel, the immunoprecipitate by anti‐His tag antibody contained many cellular proteins from the 3CL^pro^‐expressing cells ([Fig. 4](#feb2s0014579305011932-fig4){ref-type="fig"}A, lane 6), while only a few proteins from mock cells ([Fig. 4](#feb2s0014579305011932-fig4){ref-type="fig"}A, lane 3). Of the cellular proteins in the immunoprecipitate, a 68‐kDa -- immunoreactive band for the dimer 3CL^pro^ was found using Western blotting with anti‐His tag antibody ([Fig. 4](#feb2s0014579305011932-fig4){ref-type="fig"}B, lane 6). In addition, Western blot analysis with anti‐V‐ATPase G1 polyclonal antibodies demonstrated a major 13‐kDa band for cellular V‐ATPase G1 protein in the 3CL^pro^‐precipitated pellet ([Fig. 4](#feb2s0014579305011932-fig4){ref-type="fig"}C, lane 6). The result confirmed the interaction between 3CL^pro^ and V‐ATPase G1 in the HL‐CZ cells. Since V‐ATPase in the plasma and lysosomal membranes is the major proton‐extruding molecule for controlling cytosolic pH~i~ \[[21](#feb2s0014579305011932-bib-bib21){ref-type="ref"}, [22](#feb2s0014579305011932-bib-bib22){ref-type="ref"}\], the cytosolic pH~i~ in SARS‐CoV 3CL^pro^ -- expressing cells and pcDNA3.1‐expressing cells was determined by the fluorescence of SNARF‐1 ([Fig. 4](#feb2s0014579305011932-fig4){ref-type="fig"}D). Cytosolic pH~i~ of SARS‐CoV 3CL^pro^ -- expressing cells (pH~i~ = 7.70 ± 0.002) was significantly lower (*t* test, *P* \< 0.05) than that of pcDNA3.1‐expressing cells (pH~i~ = 7.79 ± 0.009).

![Cell‐based co‐immunoprecipitation (A--C) and decrease intracellular pH (D) by SARS‐CoV 3CL^pro^ protease. The cell lysates of 3CL^pro^‐expressing cells and mock cells were immunoprecipitated by anti‐His tag to 3CL^pro^. The immunoprecipitate was analyzed using Coomassie blue staining (A), and Western blotting with anti‐His tag antibody to 3CL^pro^ (B) and chicken anti‐V‐ATPase G1 polyclonal antibody (C). In addition, the 3CL^pro^‐expressing cells and mock cells were incubated with 20 μM carboxy SNARF‐1 for 30 min at room temperature. A dual‐emission ration at 580 and 640 nm of intracellular dye was detected using a fixed excitation at 514 nm, and then converted to intracellular pH (D).](FEB2-579-6089-g004){#feb2s0014579305011932-fig4}

4. Discussion {#feb2s0014579305011932-sec-4}
=============

V‐ATPase G subunit 1 was identified as a SARS‐CoV 3CL^pro^‐interacting protein by the affinity selection of a phage‐displayed human lung cDNA library ([Fig. 1](#feb2s0014579305011932-fig1){ref-type="fig"}). Co‐immunoprecipitation analysis and direct binding affinity demonstrated the specific interaction of 3CL^pro^ with V‐ATPase G subunit 1 ([2](#feb2s0014579305011932-fig2){ref-type="fig"}, [4](#feb2s0014579305011932-fig4){ref-type="fig"}). V‐ATPase resides on the membranes of acidic organelles such as secretary granules, lysosomes, and the *trans*‐Golgi network, being the major proton‐extruding molecule for maintaining acidic environment \[[21](#feb2s0014579305011932-bib-bib21){ref-type="ref"}, [22](#feb2s0014579305011932-bib-bib22){ref-type="ref"}, [23](#feb2s0014579305011932-bib-bib23){ref-type="ref"}, [24](#feb2s0014579305011932-bib-bib24){ref-type="ref"}, [25](#feb2s0014579305011932-bib-bib25){ref-type="ref"}\]. V‐ATPase is a multisubunit complex with two functional domains, namely, the peripheral V~1~ domain and the integral V~0~ domain. V‐ATPase G subunit 1 belongs to the accessory V1 subunits, being responsible for ATP hydrolysis. Interestingly, human papillomavirus 16 (HPV16) E5 protein has been demonstrated to bind to the 16‐kDa subunit of the vacuolar H(+)‐ATPase (16 K) [\[26\]](#feb2s0014579305011932-bib-bib26){ref-type="ref"}, and to inhibit the assembly, stability and complex formation of the V‐ATPase [\[27\]](#feb2s0014579305011932-bib-bib27){ref-type="ref"}. Our findings are in agreement with the previous reports \[[26](#feb2s0014579305011932-bib-bib26){ref-type="ref"}, [27](#feb2s0014579305011932-bib-bib27){ref-type="ref"}\] showing that vacuolar H(+)‐ATPase can be involved in the virus‐induced pathogenesis.

Cleavage of the V‐ATPase G1 fusion protein by SARS‐CoV 3CL^pro^ was found in this study ([Fig. 3](#feb2s0014579305011932-fig3){ref-type="fig"}), implying that 3CL^pro^ potentially cleaves the cellular V‐ATPase G1, and affects the function of vacuolar H(+)‐ATPase. Meanwhile, a significant intracellular acidification has been demonstrated in the 3CL^pro^‐expressing cells ([Fig. 4](#feb2s0014579305011932-fig4){ref-type="fig"}D). The result correlated well with previous reports in that V‐ATPase‐specific inhibitors cause acidic pH~i~ \[[28](#feb2s0014579305011932-bib-bib28){ref-type="ref"}, [29](#feb2s0014579305011932-bib-bib29){ref-type="ref"}\], and influences cell apoptosis \[[30](#feb2s0014579305011932-bib-bib30){ref-type="ref"}, [31](#feb2s0014579305011932-bib-bib31){ref-type="ref"}\]. Recent studies demonstrate the binding interaction of V‐ATPase with F‐actin, being important for regulating in response to phosphatidylinositol 3‐kinase activity [\[32\]](#feb2s0014579305011932-bib-bib32){ref-type="ref"}. Comparing to the immunoprecipitate of mock cell extract by anti‐His tag antibody ([Fig. 4](#feb2s0014579305011932-fig4){ref-type="fig"}A, lane 3), significantly more proteins were precipitated in the 3CL^pro^‐expressing cells ([Fig. 4](#feb2s0014579305011932-fig4){ref-type="fig"}A, lane 6), in which some proteins such as F‐actin could be brought down by V‐ ATPase G1.

In conclusion, a phage displayed library encoding sequences from human lung cDNA was used to identify potential 3CL^pro^‐interacting lung proteins. V‐ATPase G1 was identified as a 3CL^pro^‐interacting protein in this study. The interaction of 3CL^pro^ with V‐ATPase G1 resulted in the cleavage of V‐ATPase G1. This interaction is likely to be involved in the virus‐induced pathogenesis.
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